-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TddvrNvw/4rajtwugL12ZLI9Zrdg0b9Rd/GqUXvty2jKFReR9FQBdTMV0/Y91jsv YwToVQLNVsyDXg2Fvbcs5g== 0000897069-09-001513.txt : 20091118 0000897069-09-001513.hdr.sgml : 20091118 20091118172413 ACCESSION NUMBER: 0000897069-09-001513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091116 FILED AS OF DATE: 20091118 DATE AS OF CHANGE: 20091118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIRK THOMAS F CENTRAL INDEX KEY: 0001258258 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 091194065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 form4_thomaskirkex.xml X0303 4 2009-11-16 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001258258 KIRK THOMAS F 2616 LIGHTHOUSE BEND DR. PONTE VERDE BEACH FL 32082 1 1 0 0 Pres & Chief Executive Officer Common Stock 2009-11-16 4 S 0 11289 13.3199 D 317510 D Option to Buy 6.02 2003-01-02 2012-01-02 Common Stock 350000 350000 D Option to Buy 13.50 2004-01-02 2013-01-02 Common Stock 100000 100000 D Option to Buy 15.67 2005-01-02 2014-01-02 Common Stock 100000 100000 D Option to Buy 8.08 2006-01-03 2015-01-03 Common Stock 100000 100000 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $13.30 to $13.42. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares and fully vested shares that total 96,441 shares of stock from an initial grant of 107,730 shares of restricted stock and performance shares made on November 13, 2008, (ii) unvested restricted shares and fully vested shares that total 97,069 shares of stock from an initial grant of 120,000 shares of restricted stock and performance shares made on August 9, 2007, and (iii) unvested restricted shares and fully vested shares that total 110,000 shares of stock from an initial grant of 110,000 shares of restricted stock made on June 12, 2006. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option vested over a four-year period from the date of grant and is now fully vested. This option became exercisable to the extent of 25% on the above date and was cumulatively exercisable to the extent of 25% each year thereafter. /s/ Teri L. Champ, attorney-in-fact 2009-11-18 -----END PRIVACY-ENHANCED MESSAGE-----